Concepedia

Joy Davis

JD

7

Publications

631

Citations

7

H-Index

1986

Active since

Affiliations

University of Alberta(Current)

Epic Sciences (United States)

Novo Nordisk (Denmark)

Joy Davis is an author at University of Alberta specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1986–2011

7

Publications

7

Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice

Juliet Emamaullee, Joy Davis, Shaheed Merani et al. · Diabetes · 2009 · 377 citations · Full text

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

Christian Toso, Michael McCall, Juliet Emamaullee et al. · Transplant International · 2009 · 78 citations

The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice

Juliet Emamaullee, Joy Davis, Rena Pawlick et al. · Diabetes · 2008 · 65 citations · Full text

Porcine Marginal Mass Islet Autografts Resist Metabolic Failure Over Time and Are Enhanced by Early Treatment with Liraglutide

Juliet Emamaullee, Shaheed Merani, Christian Toso et al. · Endocrinology · 2009 · 38 citations

The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice

Michael McCall, Christian Toso, Juliet Emamaullee et al. · Surgery · 2011 · 38 citations

, , +12

Rows per page

1–5 of 7